The Toronto Western Hospital is a major research and teaching hospital in Toronto, Ontario, Canada. It is part of the University Health Network. It has 256 beds, with 46,000 visits to its emergency department annually. It is known for neurosurgery and was one of the first centres in Canada to use the gamma knife.

There are 256 beds in Toronto Western Hospital.

During the past decade, Toronto Western Hospital conducted 233 clinical trials. In the 10-year time frame, 233 clinical trials started and 61 clinical trials were completed, i.e. on average, 26.2% percent of trials that started reached the finish line to date. In the past 5 years, 97 clinical trials started and 44 clinical trials were completed. i.e. 45.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Toronto Western Hospital" #1 sponsor was "University Health Network, Toronto" with 161 trials, followed by "University of Toronto" with 16 trials sponsored, "Hoffmann-La Roche" with 8 trials sponsored, "Sunnybrook Health Sciences Centre" with 8 trials sponsored and "Gilead Sciences" with 8 trials sponsored. Other sponsors include 199 different institutions and companies that sponsored additional 131 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Toronto Western Hospital" #1 collaborator was "University Health Network, Toronto" with 25 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 15 trials as a collaborator, "Canadian Critical Care Trials Group" with 7 trials as a collaborator, "University of Toronto" with 6 trials as a collaborator and "National Institute of Neurological Disorders and Stroke (NINDS)" with 5 trials as a collaborator. Other collaborators include 232 different institutions and companies that were collaborators in the rest 184 trials.

According to Clinical.Site data, the most researched conditions in "Toronto Western Hospital" are "Parkinson Disease" (16 trials), "Alzheimer Disease" (11 trials), "Parkinson's Disease" (11 trials), "Stroke" (10 trials) and "Obstructive Sleep Apnea" (9 trials). Many other conditions were trialed in "Toronto Western Hospital" in a lesser frequency.

Most popular intervention types in "Toronto Western Hospital" are "Drug" (182 trials), "Other" (77 trials), "Device" (60 trials), "Procedure" (55 trials) and "Biological" (18 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (58 trials), "Ribavirin" (5 trials), "Deep Brain Stimulation" (4 trials), "Dexamethasone" (4 trials) and "Ranibizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Toronto Western Hospital" are 397 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 95 active trials in "Toronto Western Hospital". 5 are not yet recruiting, 56 are recruiting, 33 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 196 completed trials in Toronto Western Hospital, 2 suspended trials, and 38 terminated clinical trials to date.

Out of the total trials that were conducted in Toronto Western Hospital, 12 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 88 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 25 trials, and there were also 130 trials that are defined as “Not Applicable".